HOME >> MEDICINE >> NEWS
Impaired gene helps non-small cell lung cancer resist drug

HOUSTON - Lung cancer cells with a defective version of a potential tumor suppressor gene are highly resistant to attack by a platinum-based drug commonly used to treat the disease, researchers at The University of Texas M. D. Anderson Cancer Center and The University of Texas Southwestern Medical Center at Dallas report in the cover article of the Oct. 1 edition of Cancer Research.

The gene may provide a potential biomarker for selecting among chemotherapy choices for non-small-cell lung cancer as well as a therapeutic target for restoring the drug cisplatin's punch in treating resistant forms of the disease, says senior author Lin Ji, Ph.D., associate professor in M. D. Anderson's Department of Thoracic and Cardiovascular Surgery.

Researchers at the two institutions, working under a joint National Cancer Institute Specialized Program of Research Excellence (SPORE) in Lung Cancer grant, have identified three tumor-suppressor genes on chromosome 3. The latest paper refines the impact of one of those genes, NPRL2, on the most common form of lung cancer.

"NPRL2 has potential predictive value for care," Ji said. "If a patient's non-small-cell lung cancer lacks an active NPRL2 gene, then cisplatin likely would not be a suitable chemotherapy."

Researchers started by analyzing NPRL2 expression in 40 different lines of non-small-cell lung cancer. They found that 21 lines expressed the gene and of those 15 lines were sensitive to cisplatin. The other 19 lines had little or no expression of NPRL2 and 15 of those were cisplatin-resistant.

Follow-up laboratory experiments with resistant cell lines showed that NPRL2 expression with cisplatin drastically limited cancer cell proliferation and increased programmed cell death (apoptosis) of cancer cells by 2 to 3 fold.

"We also demonstrated in a mouse model of human cisplatin-resistant non-small-cell lung cancer that gene therapy to restore NPRL2's function makes the tumors o
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
1-Oct-2006


Page: 1 2

Related medicine news :

1. Impaired vision common in US
2. Device helps physically disabled turn on computer
3. Case study: cross-cultural bioethics training program helps fight African brain drain
4. New drug development facility helps move medicines to market
5. Research shows aerobic exercise helps maintain muscle in elderly
6. Virtual autopsy helps identify drowning as cause of death
7. Topical retinol helps reduce wrinkles associated with natural skin aging
8. Transplanting human gut bugs into mice helps understanding of metabolic system
9. Quick, innovative procedure helps men minimize incontinence after prostatectomy
10. New research helps overcome major CPAP problem
11. MS drug helps reduce vision loss

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... August 19, 2019 , ... Professional Enrollment Concepts (PEC), a ... announces they have ranked #3056 on the 2019 Inc. 5000 Fastest-Growing Private Companies ... at the most successful companies within the American economy's most dynamic segment—its independent ...
(Date:8/17/2019)... , ... August 17, 2019 , ... ... of America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year In ... Three-Year Revenue Growth of 192% Percent , Inc. magazine today revealed that YellowTelescope ...
(Date:8/16/2019)... MANHEIM, Pa. (PRWEB) , ... August 16, 2019 ... ... of other construction safety professionals from throughout the Mid-Atlantic and North East at ... two-day interactive forum was engineered to build on existing construction safety concepts and ...
(Date:8/15/2019)... ... August 15, 2019 , ... ... "The deadline for family planning clinics to provide written assurance that they will ... Similar to the Global Gag Rule, the new policy restricts providers and ...
(Date:8/14/2019)... (PRWEB) , ... August 15, 2019 , ... ... first international clinic in Tijuana Mexico. R3 Stem Cell International is offering regenerative ... licensed in Mexico. , A full procedure costs only $2950, which includes a ...
Breaking Medicine News(10 mins):
(Date:8/15/2019)... (PRWEB) , ... August 15, 2019 , ... On Sunday, ... for Everyone Foundation to make a difference in the South LA community. Six ... cleanings, fillings , extractions , and more at the South Gate ...
(Date:8/14/2019)... ... August 14, 2019 , ... Cambria Solutions, Inc., an ... Inc. 5000 list . The Inc. 5000 is the most prestigious ranking of ... said Cambria CEO Robert Rodriguez. “We have a committed and expanding team with a ...
(Date:8/14/2019)... ... August 13, 2019 , ... A recent worldwide study ... (PCOS), one of the leading causes of infertility in women[1]. Dr. ... study also provides the first genetic evidence of a causal link between PCOS ...
Breaking Medicine Technology:
Cached News: